Contingent Consideration - Schedule of Reconciliation of Contingent Consideration Liability Related to Acquisition (Details) - USD ($) $ in Thousands	6 Months Ended		8 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Business Acquisition Contingent Consideration [Line Items]
Change in fair value of contingent consideration	$ 53	$ 398
Kuur Therapeutics, Inc.
Business Acquisition Contingent Consideration [Line Items]
Beginning balance	24,076
Ending balance	24,129		$ 24,076
Kuur Therapeutics, Inc. | Level 3 Inputs
Business Acquisition Contingent Consideration [Line Items]
Beginning balance	24,076
Ending balance	24,129		24,076
Kuur Therapeutics, Inc. | Level 3 Inputs | Fair Value, Recurring
Business Acquisition Contingent Consideration [Line Items]
Beginning balance	24,076		19,839
Change in fair value of contingent consideration	53		4,237
Ending balance	$ 24,129		$ 24,076